Jean - Pierre Issa, MD, Director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine and co-Leader of the Cancer
Epigenetics Program at the Fox Chase Cancer Center is
lead author of the study, which has been published August 19 in the journal, Lancet Oncology.